In this webinar, Dr. Bert Blaauw elucidates skeletal muscle regulatory pathways and offers approaches to tackle muscle deficits for therapy.

Dr. Blaauw will present a detailed exploration of the regulatory pathways underpinning adult skeletal muscle mass and function, focusing particularly on the Akt-mTORC1 signaling pathway. He will clarify the misconception that muscle mass and size are synonymous, explaining that increased size doesn’t always mean enhanced function. The critical intracellular processes bolstered by muscle activity and exercise, which contribute to muscle strength and performance will also be presented. Finally, Dr. Blaauw will introduce a strategic workflow to identify and address muscle deficits in dysfunctional muscles, a key step for targeted therapeutic interventions.

Key Topics Include:

  • How mass and size do not always go together
  • Which intracellular processes are important in increasing muscle function
  • How muscle activity/exercise impinges on some of these processes
  • Workflow to identify sites of muscle deficit in dysfunctional muscles

Presenters

Bert Blaauw, PhD

Associate Professor/PI
Department of Biomedical Sciences/Venetian Institute of Molecular Medicine
University of Padova

Bert Blaauw is an academic researcher from University of Padua. During the first phase of his independent career, he led the work that identified the functional role of mTORC1 in muscle homeostasis and growth. In the lab, they set up various approaches to determine muscle function in whole muscles in vivo, isolated muscles ex-vivo, and isolated muscle fibers in vitro. This in-depth analysis of muscle function has allowed the lab to link changes in muscle signaling or structural proteins to alterations in muscle function, and vice-versa.

Production Partner

Additional Content From Aurora Scientific, Inc.

Cut and Paste of Myosin Binding Protein-C in Striated Muscles

Cut and Paste of Myosin Binding Protein-C in Striated Muscles

Dr. Samantha Harris discusses the development of three new mouse models in her lab, engineered to target and replace specific myosin binding protein-C paralogs in muscle fibers and impact of their mutations on skeletal and cardiac muscle diseases.
Integrating Patient Engagement and Trainee Development in Pre-Clinical Research

Integrating Patient Engagement and Trainee Development in Pre-Clinical Research

Christopher Perry, PhD discusses how his laboratory aims to discover mechanisms by which metabolic dysfunction causes muscle weakness and apply these findings to develop new therapies for muscle disorders. Homira Osman, PhD provides a particular focus on leveraging scientific findings for practice and policy and linking trainees with patient communities.

Additional Content From American Physiological Society

Related Content